These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 176784)

  • 1. Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction.
    Mandel B
    Virology; 1976 Feb; 69(2):500-10. PubMed ID: 176784
    [No Abstract]   [Full Text] [Related]  

  • 2. VP 4, the D-reactive part of poliovirus.
    Breindl M
    Virology; 1971 Dec; 46(3):962-4. PubMed ID: 4332986
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the nonneutralizable fraction of poliovirus.
    Lewenton-Kriss S; Mandel B
    Virology; 1972 Jun; 48(3):666-78. PubMed ID: 4337990
    [No Abstract]   [Full Text] [Related]  

  • 4. [Principles of formation in viral infections of immune complexes, their persisting fraction and its neutralization with antiglobulin, complement and homoreactant].
    Pervikov IuV; Voroshilova MK
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):18-24. PubMed ID: 204134
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein.
    Emini EA; Dorner AJ; Dorner LF; Jameson BA; Wimmer E
    Virology; 1983 Jan; 124(1):144-51. PubMed ID: 6186073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of rabbit IgM and IgG antibody in intratypic differentiation of poliovirus type I strains.
    Pervikov YuV ; Gracheva LA; Voroshilova MK; Chumakov MP
    Arch Gesamte Virusforsch; 1973; 43(1):7-13. PubMed ID: 4367376
    [No Abstract]   [Full Text] [Related]  

  • 7. Naturally occurring antiglobulin factors in virus neutralization: homoreactant as a factor enhancing neutralization of the infectious complex of poliovirus with the Fab' antibody fragment.
    Kulberg AJ; Pervikov JV
    Infect Immun; 1976 Feb; 13(2):322-5. PubMed ID: 177361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chromatographic determination of polio antibodies in IgG and IgM fractions of the serum and comparison of results with the neutralization test].
    Szöllösy E; Petheö G; Hils J; Böthig B
    Acta Microbiol Acad Sci Hung; 1972; 19(1):55-61. PubMed ID: 4346733
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutralization of T-even bacteriophage: the role of tail-sheath antigen in indirect neutralization.
    Stemke GW
    Can J Microbiol; 1974 May; 20(5):649-55. PubMed ID: 4598862
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliovirus neutralization and the percentage law. Brief report.
    Brioen P; Boeyé A
    Arch Virol; 1985; 83(1-2):105-11. PubMed ID: 2982345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody formation in cell cultures: immunoglobulins, cells and intercellular relationships during the secondary immune response to poliovirus.
    Teodorescu M
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):117-33. PubMed ID: 4328001
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of type 1 poliovirus by electrophoretic analysis.
    Mandel B
    Virology; 1971 Jun; 44(3):554-68. PubMed ID: 4332969
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenovirus neutralization--behavior of virion derived capsid components in the production of in vitro neutralizing antibody.
    Shortridge KF
    Microbios; 1972; 5(20):265-72. PubMed ID: 4673679
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenic specificity of poliovirus-related particles.
    Ghendon YZ; Yakobson EA
    J Virol; 1971 Oct; 8(4):589-90. PubMed ID: 4331656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization.
    Emini EA; Ostapchuk P; Wimmer E
    J Virol; 1983 Nov; 48(2):547-50. PubMed ID: 6194315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide priming of a poliovirus neutralizing antibody response.
    Wimmer E; Emini EA; Jameson BA
    Rev Infect Dis; 1984; 6 Suppl 2():S505-9. PubMed ID: 6330847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.
    Icenogle J; Gilbert SF; Grieves J; Anderegg J; Rueckert R
    Virology; 1981 Nov; 115(1):211-5. PubMed ID: 6270899
    [No Abstract]   [Full Text] [Related]  

  • 18. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
    Rombaut B; Vrijsen R; Boeyé A
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of specificity of poliovirus inhibitors with inhibitor-resistant mutants of a strain of type 1 poliovirus.
    Hashimoto N
    J Immunol; 1975 Aug; 115(2):569-74. PubMed ID: 168261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on poliovirus inhibitors in sera of domestic animals. 3. A comparison of physico-chemical properties of poliovirus inhibitors and specific antibodies.
    Urasawa S; Urasawa T; Chiba S; Kanamitsu M
    Jpn J Med Sci Biol; 1968 Jun; 21(3):173-83. PubMed ID: 4301954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.